Aristides Capital’s Pediatrix Medical MD Stock Holding History

Aristides Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-26,445	Closed	-$246K	–	320
2023 Q4	$246K	Buy	+26,445	New	+$274K	0.09%	173

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aristides Capital's MD Position: Q1 2024 in Review

Aristides Capital sold out of Pediatrix Medical (MD) in Q1 2024, closing a stake of 26,445 shares — an estimated $246K sold.

Aristides Capital first reported a position in MD in Q4 2023 and held it in 1 quarter. The position peaked at $246K in Q4 2023. 213 funds tracked by Wall St. Rank hold MD as of Q1 2024.

Aristides Capital reported no remaining Pediatrix Medical position as of Q1 2024 after selling out during the quarter.
Aristides Capital sold 26,445 Pediatrix Medical shares in Q1 2024, an estimated $246K.
Aristides Capital first reported a position in Pediatrix Medical in Q4 2023 and held it in 1 quarter.
Aristides Capital's Pediatrix Medical position peaked at $246K in Q4 2023.
213 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2024.

Based on Aristides Capital's 13F filing for Q1 2024, filed 15 May 2024.